Based on advice from the TRP, the Board divided eligible Round 9 proposals into five Categories, as follows:
You are here
The Global Fund Board has approved five grants in the "first learning wave" of National Strategy Applications (NSAs). The approved proposals requested $434 million over the first two years and $756 million over their lifetimes (up to five years).
GFO's next issue, targeted for publication in the next few days, will provide information on the other key decisions made at the November 9-11 Board meeting.
In an unexpected development, the Board of the Global Fund yesterday agreed in principle that Round 9 will be launched nearly six months earlier than had been anticipated. The Board also agreed that CCMs whose Round 8 proposals narrowly fail to be approved will be permitted to resubmit those proposals as part of Round 9, after they address shortcomings pointed out by the Technical Review Panel (TRP).
The main decisions made by the Global Fund Board at the meeting that ended yesterday were, in chronological order, as follows. (For precise wording of what the Board agreed, check in
www.theglobalfund.org/documents/board/17/GF-B17-DecisionPoints.pdf for the Decision Points specified below.)
Large parts of the Global Fund Board meeting that ended yesterday were mind-numbingly boring, sometimes inevitably so and sometimes not. However, things certainly came to life when Round 9 was discussed.
The Board's decision regarding Round 9 creates some important new options that every CCM that is currently working on a Round 8 proposal needs to think hard about.
The Global Fund Board has approved three of the seven Round 7 proposals whose original rejection had been appealed by the applicants. The newly approved proposals are a malaria proposal from Azerbaijan that will cost $2.5 million over the first two years, a TB proposal from Cambodia that will cost $8.7 million, and a TB proposal from Zambia that will cost $4.1 million.
Round 7 applicants to the Global Fund submitted fewer, but bigger and better, proposals than applicants in all previous rounds.
On 22 April 2007, the Boston Globe ran the following article by John Donnelly.
World health fund has new director, new challenges
The fight to save tens of millions of lives from AIDS and other infectious diseases has reached a critical crossroads, and Michel Kazatchkine stands in the middle of it.
After Michel Kazatchkine was selected to be the next Executive Director of the Global Fund, GFO interviewed him by phone. Here are excerpts from what he said.